Membranoproliferative glomerulonephritis

MONDO:0002461

Inflammation of the glomeruli characterized by deposits at the intraglomerular mesangium, resulting in thickening of the glomerular basement membrane, activation of complement, and impaired kidney function secondary to damaged glomeruli.

Also known as: membranoproliferative glomerulonephritis, membranoproliferative glomerulonephritis (disease)

14 clinical trials for this condition and its sub-types, 11 tagged with Membranoproliferative glomerulonephritis itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Glomerulonephritis (457)

Including sub-types (14) Tagged with Membranoproliferative glomerulonephritis (11)

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 3 Completed 2

New drug iptacopan studied for rare kidney disease C3G

Disease control Not yet recruiting

This study looks back at the experiences of 35 adults with a rare kidney disease called C3G who received the drug iptacopan through a special early access program in Spain. Researchers will collect information on patient health, lab results, and how the disease responds to treatm…

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Sep 19, 2026 00:00 UTC

Membranoproliferative glomerulonephritis

Where it sits in the disease tree

New drug iptacopan studied for rare kidney disease C3G